SCI REP:中国卒中亚型和血管危险因素的变化趋势!

2018-03-22 xing.T MedSci原创

总之,卒中亚型的比例发生了显著变化。需要加强降压治疗来控制ICH、SAH和SVD缺血性卒中的发生率。提高IS的病因学检测及降脂治疗是有效的,心源性栓塞的检测也进一步加强。

中国经济快速发展导致人们的生活方式和医疗技术发生了显著的变化。探索卒中的亚型趋势是很有必要的,以为医生的早期诊断和治疗提供重要的见解。

近日,Scientific reports杂志上发表了一篇研究文章,研究人员纳入了从2006年到2015年期间的卒中患者。研究人员对卒中亚型和血管危险因素的趋势进行了调查。

该研究共有5521例患者,其中包含4534例(82.1%)缺血性脑卒中(IS)患者,813例(14.7%)脑出血(ICH)患者,174例(3.2%)蛛网膜下腔出血(SAH)患者。IS患者所占的比例有所增加,ICH和SAH患者的比例均降低(P<0.001)。在卒中亚型患者的发病年龄和高血压保持稳定。在IS患者中,第一个7年内,大动脉粥样硬化(LAA)卒中从17%增加到30.8%,最终减少到24.1%。小血管疾病(SVD)卒中从15.5%增加到39.6%,病因不明(UE)卒中从52.7%下降到了26%,其他保持稳定。低密度脂蛋白水平明显下降,越来越多的患者接受了颅内动脉检查(P<0.001)。

总之,卒中亚型的比例发生了显著变化。需要加强降压治疗来控制ICH、SAH和SVD缺血性卒中的发生率。提高IS的病因学检测及降脂治疗是有效的,心源性栓塞的检测也进一步加强。

原始出处:

Danyang Tian,et al. Trends in stroke subtypes and vascular risk factors in a stroke center in China over 10 years.Scientific reports.2018. https://www.nature.com/articles/s41598-018-23356-9

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1968775, encodeId=6e3a1968e75d9, content=<a href='/topic/show?id=2b323600566' target=_blank style='color:#2F92EE;'>#卒中亚型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36005, encryptionId=2b323600566, topicName=卒中亚型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Sun Oct 21 21:05:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948923, encodeId=194c1948923b2, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Jul 06 10:05:00 CST 2018, time=2018-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025991, encodeId=189d102599198, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 22 22:05:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1968775, encodeId=6e3a1968e75d9, content=<a href='/topic/show?id=2b323600566' target=_blank style='color:#2F92EE;'>#卒中亚型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36005, encryptionId=2b323600566, topicName=卒中亚型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Sun Oct 21 21:05:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948923, encodeId=194c1948923b2, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Jul 06 10:05:00 CST 2018, time=2018-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025991, encodeId=189d102599198, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 22 22:05:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1968775, encodeId=6e3a1968e75d9, content=<a href='/topic/show?id=2b323600566' target=_blank style='color:#2F92EE;'>#卒中亚型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36005, encryptionId=2b323600566, topicName=卒中亚型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f54230, createdName=xlysu, createdTime=Sun Oct 21 21:05:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1948923, encodeId=194c1948923b2, content=<a href='/topic/show?id=1e4789584b0' target=_blank style='color:#2F92EE;'>#血管危险因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89584, encryptionId=1e4789584b0, topicName=血管危险因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f49517, createdName=xinmeili, createdTime=Fri Jul 06 10:05:00 CST 2018, time=2018-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1025991, encodeId=189d102599198, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Thu Mar 22 22:05:00 CST 2018, time=2018-03-22, status=1, ipAttribution=)]
    2018-03-22 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0